Change search criteria ↓

Search results

332 projects found matching your search criteria:

  1. 51. Histidine Biosynthetic Pathway in Plants: Structural and Functional Studies as a Framework for the Design of Inhibitors …

    Principal investigator: dr hab. Miłosz Ruszkowski

    Instytut Chemii Bioorganicznej PAN

    Call: SONATA 14, Panel: NZ1

  2. 52. In search of specific inhibitors of myeloperoxidase, from mechanistic studies to application in enzymatic and cellular s…

    Principal investigator: dr Radosław Michalski

    Politechnika Łódzka, Wydział Chemiczny

    Call: SONATA 14, Panel: ST4

  3. 53. The significance of cancer specific PFK-II (PFKFB3 and PFKFB4) isoenzymes inhibition in overcoming resistance to BRAF in…

    Principal investigator: Sonia Elżbieta Trojan

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum

    Call: PRELUDIUM 16, Panel: NZ5

  4. 54. De novo designed, structurally extended peptide foldamers and their use for construction of PD-1/PD-L1 interaction inhib…

    Principal investigator: dr hab. Łukasz Berlicki

    Politechnika Wrocławska

    Call: OPUS 16, Panel: ST5

  5. 55. CP protease of the O'nyong-nyong virus: substrate profiling, design and synthesis of inhibitors and activity-based probe…

    Principal investigator: dr hab. Marcin Sieńczyk

    Politechnika Wrocławska

    Call: OPUS 15, Panel: NZ6

  6. 56. Interaction and PK/PD studies of phosphodiesterase inhibitors in a murine model of autoimmune hepatitis

    Principal investigator: dr Artur Jerzy Świerczek

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: PRELUDIUM 15, Panel: NZ7

  7. 57. Novel human topoisomerase II inhibitors as anticancer agents

    Principal investigator: dr Barbara Kaproń

    Uniwersytet Medyczny w Lublinie, Wydział Nauk o Zdrowiu

    Call: PRELUDIUM 15, Panel: NZ7

  8. 58. Thiol oxidoreductases of Helicobacter spp. - biochemical and structural characterization of the H. hepaticus Dsb system …

    Principal investigator: prof. Dariusz Bartosik

    Uniwersytet Warszawski, Wydział Biologii

    Call: OPUS 15, Panel: NZ1

  9. 59. Organometallic compounds as selective inhibitors of selected multidrug resistance proteins

    Principal investigator: dr hab. Damian Nestor Plażuk

    Uniwersytet Łódzki, Wydział Chemii

    Call: OPUS 15, Panel: ST5

  10. 60. New Hexokinase II inhibitors, in search of innovative therapeutic approaches to cancer treatment

    Principal investigator: Mateusz Dawid Tomczyk

    Politechnika Śląska, Wydział Chemiczny

    Call: PRELUDIUM 14, Panel: NZ7

  11. 61. Histone deacetylase inhibitors as potential modulatory factors of inflammatory response induced in the rat brain after n…

    Principal investigator: dr hab. Małgorzata Nałęcz

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 14, Panel: NZ3

  12. 62. BET Bromodomain Inhibitors and improvement of glioblastoma therapy

    Principal investigator: prof. Witold Korytowski

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: OPUS 14, Panel: NZ5

  13. 63. Novel inhibitors of herpes virus protease

    Principal investigator: Magdalena Anna Pachota

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: PRELUDIUM 14, Panel: NZ6

  14. 64. Polymeric inhibitors of Zika virus

    Principal investigator: prof. Maria Nowakowska

    Uniwersytet Jagielloński, Wydział Chemii

    Call: OPUS 14, Panel: ST5

  15. 65. 7,8-disubstituted theophylline derivatives that are potent inhibitors of selected PDE isoenzymes as a new compounds with…

    Principal investigator: dr Katarzyna Anna Wójcik-Pszczoła

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 14, Panel: NZ7

  16. 66. Inhibitors of BTLA-HVEM complex formation as potential targets for cancer immunotheraphy

    Principal investigator: dr Marta Marcelina Spodzieja

    Uniwersytet Gdański, Wydział Chemii

    Call: SONATA 13, Panel: ST5

  17. 67. Molecular mechanism of action and therapeutic effect of 5-aza-2'-deoxycytidine and topoisomerase inhibitors combination …

    Principal investigator: dr hab. Wojciech Kałas

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: OPUS 13, Panel: NZ5

  18. 68. Biomedical materials modification by proteolytic enzymes inhibitors

    Principal investigator: prof. Anna Beata Jarosz-Wilkołazka

    Uniwersytet Marii Curie-Skłodowskiej w Lublinie, Wydział Biologii i Biotechnologii

    Call: OPUS 13, Panel: NZ7

  19. 69. Proteomic analysis of myeloma plasma cells to determine proteins and pathways involved in acquired resistance to proteas…

    Principal investigator: dr Dominik Dytfeld

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski II

    Call: OPUS 13, Panel: NZ5

  20. 70. Anilide derivatives of long-chain cyclic amines as multifunctional serotonin receptors ligands and phosphodiesterase 7 i…

    Principal investigator: dr Agnieszka Wioleta Jankowska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: PRELUDIUM 13, Panel: NZ7

  21. 71. Analysis of the role of pseudorabies virus-encoded microRNAs on virus infection using RNA inhibitors.

    Principal investigator: Weronika Aniela Hoffmann

    Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

    Call: PRELUDIUM 13, Panel: NZ6

  22. 72. Exploring Baltic Sea cyanobacteria for small-molecule inhibitors of microRNA function

    Principal investigator: prof. Paweł Michał Brzuzan

    Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Geoinżynierii

    Call: OPUS 13, Panel: NZ9

  23. 73. Synthesis of 2-phosphonocarboxylates as potential covalent inhibitors of Rab geranylgeranyl transferase

    Principal investigator: Joanna Natalia Małolepsza

    Politechnika Łódzka, Wydział Chemiczny

    Call: PRELUDIUM 12, Panel: ST5

  24. 74. Allosteric inhibitors of proteasome - optimization of the structure of PR39 analogs in order to achieve greater efficien…

    Principal investigator: Małgorzata Giżyńska

    Uniwersytet Gdański, Wydział Chemii

    Call: PRELUDIUM 12, Panel: ST5

  25. 75. In vitro studies of NaA nanozeolite functionalized with integrins inhibitor- cilengitide and labeled with radium radioiz…

    Principal investigator: dr Sylwia Męczyńska-Wielgosz

    Instytut Chemii i Techniki Jądrowej

    Call: SONATA 12, Panel: NZ7

  26. 76. Insights into biological activity and mechanism of action of novel styrylquinazoline derivatives as tyrosine kinase inhi…

    Principal investigator: Katarzyna Anna Malarz

    UNIWERSYTET ŚLĄSKI, Wydział Matematyki, Fizyki i Chemii

    Call: PRELUDIUM 12, Panel: NZ7

  27. 77. Use of novel small molecule inhibitors of PERK kinase dependent UPR pathway for the colorectal cancer treatment

    Principal investigator: prof. Adam Janusz Dziki

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: OPUS 12, Panel: NZ5

  28. 78. Oxopiperazine peptidomimetics as potential PEX14-PE5 protein-protein interaction inhibitors

    Principal investigator: dr hab. Maciej Filip Dawidowski

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

    Call: OPUS 12, Panel: NZ7

  29. 79. Electrochemical analysis of the corrosion process of Al2Cu intermetallic phase in the acidic solutions, in the presence …

    Principal investigator: dr Przemysław Szczepan Kwolek

    Politechnika Rzeszowska im. Ignacego Łukasiewicza, Wydział Budowy Maszyn i Lotnictwa

    Call: SONATA 12, Panel: ST5

  30. 80. Identification of the mechanism of sensitization of human ovarian cancer cells to anticancer drugs by the DNA double str…

    Principal investigator: Anna Macieja

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: PRELUDIUM 12, Panel: NZ7

  31. 81. The role of arginase-1 in antitumor efficacy of cancer immunotherapy using checkpoint inhibitors

    Principal investigator: prof. Dominika Anna Nowis

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

    Call: OPUS 12, Panel: NZ6

  32. 82. DEVELOPMENT AND ANALYSIS OF SMALL COMPOUNDS AS CANDIDATE INHIBITORS OF PLANT GROUP A PROTEIN PHOSPHATASES TYPE 2C

    Principal investigator: dr hab. Agnieszka Wioletta Ludwików

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

    Call: SONATA BIS 6, Panel: NZ3

  33. 83. Analysis of the effectiveness of anticancer activity of tyrosine kinase inhibitors combined with nanoparticles in in vit…

    Principal investigator: dr Natalia Piergies

    Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego PAN

    Call: SONATA 11, Panel: ST4

  34. 84. Structure and function characterization of newly discovered unique inhibitors of proteases

    Principal investigator: prof. Jan Stanisław Potempa

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: OPUS 11, Panel: NZ1

  35. 85. Use of novel small molecule inhibitors of PERK kinase dependent UPR pathway for the primary open-angle glaucoma treatmen…

    Principal investigator: prof. Ireneusz Jacek Majsterek

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: OPUS 11, Panel: NZ5

  36. 86. Anticancer activity of novel tubulin polymerization inhibitors obtained by the chemical modification of colchicine

    Principal investigator: dr hab. Adam Włodzimierz Huczyński

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

    Call: OPUS 11, Panel: ST5

  37. 87. New opportunities for use of PERK kinase inhibitors in eIF2alfa factor-dependant signalling pathway in antitumor therapy

    Principal investigator: dr Wioletta Julia Rozpędek-Kamińska

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: PRELUDIUM 10, Panel: NZ3

  38. 88. Design, synthesis and biological evaluation of the new steroid sulfatase (STS) inhibitors based on sulfamate analogs con…

    Principal investigator: Mateusz Daśko

    Politechnika Gdańska, Wydział Chemiczny

    Call: PRELUDIUM 10, Panel: NZ7

  39. 89. Modification of cellular aging in vitro by inhibitors of non-enzymatic protein modifications

    Principal investigator: prof. Grzegorz Bartosz

    Uniwersytet Rzeszowski, Kolegium Nauk Przyrodniczych

    Call: OPUS 9, Panel: NZ3

  40. 90. The role of DNA methylation in enhancing the sensitivity of colorectal cancer cells to topoisomerase inhibitors.

    Principal investigator: Alicja Patrycja Pawlak

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: PRELUDIUM 9, Panel: NZ3

  41. 91. New approach in bisubstrate analogs inhibitors designing.

    Principal investigator: dr Maria Izabella Winiewska-Szajewska

    Instytut Biochemii i Biofizyki PAN

    Call: PRELUDIUM 9, Panel: NZ1

  42. 92. Analysis of selected physicochemical, biological and pharmacological properties of biomedical materials modified by synt…

    Principal investigator: dr Katarzyna Szałapata

    Uniwersytet Marii Curie-Skłodowskiej w Lublinie, Wydział Biologii i Biotechnologii

    Call: PRELUDIUM 8, Panel: NZ7

  43. 93. Synthesis of fluorogenic substrates, inhibitors and activity-based probes of human neutrophil proteinase NSP4 and its ev…

    Principal investigator: prof. Adam Jerzy Lesner

    Uniwersytet Gdański, Wydział Chemii

    Call: OPUS 8, Panel: ST5

  44. 94. EGFR and c-Met inhibitors as factors limiting formation of invadopodia in human melanoma cells

    Principal investigator: dr hab. Dorota Nowak

    Uniwersytet Wrocławski, Wydział Biotechnologii

    Call: OPUS 8, Panel: NZ5

  45. 95. New inhibitors of catalytic subunit of telomerase.

    Principal investigator: prof. Maciej Bagiński

    Politechnika Gdańska, Wydział Chemiczny

    Call: OPUS 7, Panel: NZ7

  46. 96. Studies on the influence of selected inhibitors of kinases involved in signaling pathways in tumor cells on NK cell cyto…

    Principal investigator: Marta Siernicka

    Warszawski Uniwersytet Medyczny, I Wydział Lekarski

    Call: PRELUDIUM 7, Panel: NZ6

  47. 97. The use of microRNA inhibitors for restoration of the physiological expression of sodium iodide symporter NIS in thyroid…

    Principal investigator: Marta Elżbieta Kotlarek

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

    Call: PRELUDIUM 7, Panel: NZ2

  48. 98. Design, chemical synthesis and biological activity of inhibitors of matriptase-2.

    Principal investigator: Agata Elżbieta Gitlin-Domagalska

    Uniwersytet Gdański, Wydział Chemii

    Call: PRELUDIUM 7, Panel: ST5

  49. 99. Structure optimization of inhibitor for paracaspase MALT1

    Principal investigator: dr Paulina Maria Kasperkiewicz

    Politechnika Wrocławska, Wydział Chemiczny

    Call: PRELUDIUM 6, Panel: ST5

  50. 100. Sensitization of cancer cells to chemotherapy by novel DNA repair inhibitors

    Principal investigator: dr hab. Tomasz Popławski

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: OPUS 6, Panel: NZ7

Graphic design and implementation: Jakub Piotrowski